Actively Recruiting
Screening for Hepatitis B, Hepatitis C, and AIDS Viruses in Drug Users Using Dried Blood Spot Testing
Led by University Hospital, Rouen · Updated on 2026-02-17
500
Participants Needed
11
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to screen people who use drugs for hepatitis B, hepatitis C, and AIDS viruses. It focuses on identifying active infections using a simple blood collection method. The study is sponsored by the University Hospital, Rouen, and does not involve experimental drug treatments but diagnostic testing. Participants will have their blood collected using a Dried Blood Spot method, which is a minimally invasive way to collect samples. The study includes individuals who are former or current intravenous or nasal drug users, as well as those on opiate substitution therapy. The screening occurs at the start of participation to detect active infections. Participants will be assessed on the first day for active hepatitis B, hepatitis C, and AIDS infections. The main measurements are the number of individuals found to have active infections of these viruses. This study does not involve any treatment and focuses on diagnostic testing and data collection during the initial visit.
CONDITIONS
Brief Title
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Research Team
G
Ghassan RIACHI, MD
J
Julien BLOT
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
